Dr. Brian Conway is the medical director of the Vancouver Infectious Diseases Centre as well as an assistant professor in the Department of Pharmacology and Therapeutics at the University of British Columbia. He also serves as the HIV/AIDS consultant to the Gastown Medical Clinic, which is dedicated to treating injection drug users. He is also the chair-Elect of the Canadian Pediatric AIDS Research Group. His medical research in the field of HIV has involved the measurement of HIV drug resistance, acute and early HIV infection, and simplified antiretroviral regimens.

Dr. Conway earned a Doctor of Medicine and Master of Surgery degree and completed a post-graduate fellowship at McGill University. Following his time at McGill, he completed fellowships in infectious diseases at the University of Manitoba and in HIV/AIDS at Harvard University.

He was a principle investigator of CTN 214, which evaluated the effectiveness of one year of highly active antiretroviral therapy in slowing down the progression of HIV in adults recently infected. He has acted as co-investigator in many CTN studies, including CTN 286: TriiAdd Study, CTN 293: REPRIEVE Trial, and CTN 247: Canadian cohort of HIV+ slow progressors. He has also contributed to numerous CTN research publications.